Effectiveness and Safety of Ticagrelor Implementation in Patients with Acute Coronary Syndrome undergoing Percutaneous Coronary Intervention: A Cohort Study in Western Denmark

BACKGROUND: Ticagrelor was introduced in Denmark in 2011 after randomised data showed its superiority over clopidogrel for patients with acute coronary syndrome (ACS). We assessed the effectiveness and safety of ticagrelor implementation in ACS patients undergoing percutaneous coronary intervention...

Descripción completa

Detalles Bibliográficos
Autores principales: Thrane, Pernille Gro, Olesen, Kevin Kris Warnakula, Würtz, Morten, Gyldenkerne, Christine, Madsen, Morten, Jensen, Lisette Okkels, Raungaard, Bent, Sørensen, Henrik Toft, Thim, Troels, Kristensen, Steen Dalby, Maeng, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802857/
https://www.ncbi.nlm.nih.gov/pubmed/35146473
http://dx.doi.org/10.1016/j.lanepe.2021.100301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802857/
https://www.ncbi.nlm.nih.gov/pubmed/35146473
http://dx.doi.org/10.1016/j.lanepe.2021.100301

Ejemplares similares